NEW YORK (Reuters Health) – Four out of five children with juvenile idiopathic arthritis had a good clinical response to abatacept during a long-term open-label extension trial. The…
NEW YORK (Reuters Health) – In patients with psoriatic arthritis, once weekly etanercept (Enbrel) is suitable for joint symptoms but twice weekly dosing is needed to best address…
NEW YORK (Reuters Health) – For acute gout flare, a 1-hour low-dose oral colchicine regimen offers comparable efficacy and better tolerability than the more common 6-hour high-dose regimen,…
NEW YORK (Reuters Health) – Intra-articular corticosteroids are a good early treatment for knee osteoarthritis pain, according to a meta-analysis by Boston-based researchers. However, hyaluronic acid injected into…
NEW YORK (Reuters Health) – In recent-onset active rheumatoid arthritis (RA), regular medication adjustments based on disease-activity scores (DAS) improves clinical outcomes and possibly radiological outcomes as well,…
NEW YORK (Reuters Health) – Liver enzyme elevations occur in up to a third of patients with inflammatory arthritis who take methotrexate, leflunomide, or both, a cohort study…
NEW YORK (Reuters Health) – A single 6-mL intra-articular injection of hylan G-F 20 (Synvisc-One, Genzyme Biosurgery) safely reduces knee osteoarthritis pain for 26 weeks, results of a…
NEW YORK (Reuters Health) – Abatacept, an agent that modifies the costimulatory signal required for T-cell activation, does not increase malignancy rates in patients with rheumatoid arthritis (RA),…
NEW YORK (Reuters Health) – In patients receiving glucocorticoids for inflammatory diseases, adverse events are very common, even at low to medium doses, according to a meta-analysis by…
NEW YORK (Reuters Health) – A 12-year study in middle-aged adults suggests that knee pain is frequently the first sign of knee osteoarthritis. “Knee pain is common, and…